Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Better Therapeutics Inc
BTTXCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.bettertx.com
ISIN
US08773T1043
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCMKTS
Capitalization
5 452 USD
Yield for 12 month
-99.94 %
1Y
3Y
5Y
10Y
15Y
BTTX
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California. Address: 548 Market Street, San Francisco, CA, United States, 94104
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-2 729 000 USD
Current Quarter
-841 000 USD
Last Quarter
-797 000 USD
Key Figures BTTX
1 year
3 years
5 years
10 years
EBITDA
-29 175 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-95.05 %
PEG Ratio
–
Return On Equity TTM
-1021.64 %
Wall Street Target Price
5.25 USD
Revenue TTM
–
Book Value
-0.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-674 000 USD
Earnings per share
-1.1 USD
Diluted Eps TTM
-1.1 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BTTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BTTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BTTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
74299.06
Price Sales TTM
49559.4078
Enterprise Value EBITDA
-0.4641
Price Book MRQ
2.289
Financials BTTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BTTX
For 52 weeks
0.0001 USD
0.27 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
1 987 961
200 Day MA
0.036 USD
Short Ratio
0.94
Shares Short
2 126 165
Short Percent
6.21 %
BeatStart